APTO News and Press, Aptose Biosciences Inc. From 10/26/21

SAN DIEGO and TORONTO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, will report financial results for the quarter ended September 30...

Are These Robinhood Penny Stocks On Your List Right Now? One of the important things to realize about penny stocks today is that certain traders can/can’t access certain companies. Thanks to the rise in popularity of platforms like Reddit, social media has helped connect traders ...

Aptose's second quarter update was undramatic, with management indicating that they've fully enrolled their Phase I luxeptinib studies at 750mg and are moving on to 900mg. Dose escalation awaits in the APTO-253 AML/MDS study, but management is also going to start enrolling patients wi...

Aptose Biosciences Inc. (APTO) Q2 2021 Earnings Conference Call August 03, 2021 05:00 PM ET Company Participants Susan Pietropaolo - Communications Representative William Rice - Chairman, President and Chief Executive Officer Rafael Bejar - Senior Vice President and Chief Medical Officer Joti...

- Conference call and webcast at 5:00 pm EDT today - - Luxeptinib Phase 1a/b studies in AML and B cell malignancies fully enrolled at 750 mg dose - - APTO-253 Phase 1a/b study in AML / MDS treating patients at sixth dose cohort of 210 mg/m2 - SAN DIEGO and TORONTO,...

SAN DIEGO and TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, will report financial results for the quarter ended June 30, 202...

When it comes to Bay Street, and investing in general, patience is what pays. You could look at the one-month performance of TSX stocks and see thousands of dollars lost. Or you could zoom out and see what those same shares have done over the last few years — even decades. People...

The following slide deck was published by Aptose Biosciences Inc. in conjunction with this event. For further details see: Aptose Biosciences (APTO) Presents Corporate Update at EHA 2021 - Slideshow

Gainers: Novan (NOVN) +74%.Urban One (UONE) +39%.Iconix Brand (ICON) +28%.Aptinyx (APTX) +24%.Carver Bancorp (CARV) +22%.Vaxart (VXRT) +21%.Xinyuan Real Estate (XIN) +20%Broadway Financial (BYFC) +18%.Amesite (AMST) +18%.Siebert Financial (SIEB) +16%.Losers: Recon Technolo...

Gainers: Novan (NOVN) +81%, Aptinyx (APTX) +25%, Vaxart (VXRT) +39%, Progenity (PROG) +28%, Chemomab Therapeutics (CMMB) +9%.Losers: Orphazyme (ORPH) -41%, Curis (CRIS) -32%, Aptose Biosciences (APTO) -30%, Galecto (GLTO) -22%,&...